Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-14-003653
Filing Date
2014-07-14
Accepted
2014-07-14 16:58:03
Documents
12
Period of Report
2014-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K peregrine_10k-043014.htm 10-K 1103508
2 SUBSIDIARIES OF REGISTRANT peregrine_10k-ex021.htm EX-21 2056
3 CONSENT peregrine_10k-ex2301.htm EX-23.1 3033
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER peregrine_10k-ex3101.htm EX-31.1 7753
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER peregrine_10k-ex3102.htm EX-31.2 7750
6 CERTIFICATION peregrine_10k-ex32.htm EX-32 6365
  Complete submission text file 0001354488-14-003653.txt   6604221

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE pphm-20140430.xml EX-101.INS 1073893
8 XBRL SCHEMA FILE pphm-20140430.xsd EX-101.SCH 36559
9 XBRL CALCULATION FILE pphm-20140430_cal.xml EX-101.CAL 71785
10 XBRL DEFINITION FILE pphm-20140430_def.xml EX-101.DEF 130609
11 XBRL LABEL FILE pphm-20140430_lab.xml EX-101.LAB 308466
12 XBRL PRESENTATION FILE pphm-20140430_pre.xml EX-101.PRE 250351
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

EIN.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-32839 | Film No.: 14973992
SIC: 2834 Pharmaceutical Preparations